Gabapentin Tablet
Product Images NDC 60760-837

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clcr (Equation)

This text provides a formula used to calculate creatinine clearance (CLCr) for male and female patients based on their age, weight, and serum creatinine level. The formula is adjusted for female patients by multiplying the result by 0.85.*

FDA Label Image

60760-837 (Gabapentin 60760 837 60)

This text appears to be a medication label for Gabapentin tablets, USP 800mg. It contains information such as the National Drug Code (NDC), prescription numbers, dosage, and storage instructions. The label indicates that the tablets are intended for oral use and provides contact information for the manufacturer. Users are advised to follow the directions as directed.*

FDA Label Image

Figure-1 (Figure1)

This is a graph showing the weekly mean pain scores observed in the ITT population for Study 1. The graph displays the pain scores over time with a focus on the effect of Gabapentin treatment at a dosage of 3500 mg/day on pain levels.*

FDA Label Image

Figure-2 (Figure2)

FDA Label Image

Figure-3 (Figure3)

The text provides data on the proportion of responders (patients with a >50% reduction in pain score) at the endpoint in controlled PHN studies. The figure shows the comparison between two studies (Study 1 and Study 2) with different treatment groups (PBO, GBP 1800, GBP 2400). The results indicate varying percentages of responders in each group, potentially highlighting the effectiveness of different treatment doses in managing pain associated with PHN (Postherpetic Neuralgia).*

FDA Label Image

Figure-4 (Figure4)

FDA Label Image

Struc (Struct)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.